This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Prion
From Proteopedia
(Difference between revisions)
| (9 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load=' | + | <StructureSection load='' size='350' side='right' scene='Prion/Cv/3' caption='Human major prion protein complex with Cd+ (pink) and Cl- (green) ions (PDB code [[3haf]])'> |
{{Clear}} | {{Clear}} | ||
| + | __TOC__ | ||
| + | |||
| + | ==Function== | ||
| + | |||
'''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. For more details see<br /> | '''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. For more details see<br /> | ||
*[[Prion protein]]<br /> | *[[Prion protein]]<br /> | ||
*[[Human Prion Protein Dimer]]<br /> | *[[Human Prion Protein Dimer]]<br /> | ||
*[[Doppel]]<br /> | *[[Doppel]]<br /> | ||
| + | *[[Group:SMART:A Physical Model of the Structure of GNNQQNY from Yeast Prion Sup35]]<br /> | ||
Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]). | Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]). | ||
| - | + | == Dominant-negative Effects in Prion Diseases== | |
| + | |||
| + | Insights from Molecular Dynamics Simulations on <scene name='Journal:JBSD:4/Cv/2'>Mouse Prion Protein Chimeras</scene> <ref>doi 10.1080/07391102.2012.712477</ref>. | ||
The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect. | The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect. | ||
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The β2-α2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the β2-α2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>. | Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the α1 helix and N-terminal of α3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The β2-α2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the β2-α2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>. | ||
The structural features presented here indicate that stronger interactions between α1 helix and N-terminal of α3 helix are related to the resistance to PrP<sup>C</sup> → PrP<sup>Sc</sup> conversion, while the β2-α2 loop conformation may play an important role in the dominant-negative effect. | The structural features presented here indicate that stronger interactions between α1 helix and N-terminal of α3 helix are related to the resistance to PrP<sup>C</sup> → PrP<sup>Sc</sup> conversion, while the β2-α2 loop conformation may play an important role in the dominant-negative effect. | ||
| - | </StructureSection> | ||
==3D structures of prion== | ==3D structures of prion== | ||
| + | [[Prion 3D structures ]] | ||
| - | + | </StructureSection> | |
| - | + | ||
| - | *Prion short polypeptides | ||
| - | |||
| - | **[[3nve]] – ShPrP residues 138 -143 – Syrian hamster<br /> | ||
| - | **[[2kkg]] - PrP residues 23 -106 – Golden hamster - NMR<br /> | ||
| - | **[[3nvf]] – hPrP residues 138 -143 – human<br /> | ||
| - | **[[2ol9]] - hPrP residues 170 – 175<br /> | ||
| - | **[[3nhc]], [[3nhd]], [[3md4]], [[3md5]] - hPrP residues 127 – 132<br /> | ||
| - | **[[2iv5]] - hPrP residues 173 -195 – NMR<br /> | ||
| - | **[[1oei]] - hPrP residues 61 - 84 – NMR<br /> | ||
| - | **[[1oeh]] - hPrP residues 61 - 68 – NMR<br /> | ||
| - | **[[2lbg]] - hPrP residues 110 - 136 – NMR<br /> | ||
| - | **[[2iv6]] - hPrP residues 173 -195 (mutant) – NMR<br /> | ||
| - | **[[2iv4]] - hPrP residues 180 -195 – NMR<br /> | ||
| - | **[[4e1h]], [[4e1i]] - hPrP residues 177 -182 + 211-216<br /> | ||
| - | **[[3nvg]], [[3nvh]] - mPrP residues 138 -143 – mouse<br /> | ||
| - | **[[1skh]] - bPrP residues 1 – 30 - bovine<br /> | ||
| - | **[[3fva]] - ePrP residues 173 -178 – Elk<br /> | ||
| - | **[[1s4t]] - sPrP residues 135 – 155 – sheep – NMR<br /> | ||
| - | **[[1m25]] - sPrP residues 152 – 156 – NMR<br /> | ||
| - | **[[1g04]] - sPrP residues 145 – 169 – NMR<br /> | ||
| - | **[[2rmv]], [[2rmw]] - sPrP residues 142 – 166 (mutant) – NMR | ||
| - | |||
| - | *Prion | ||
| - | |||
| - | **[[3o79]] – rPrP C-terminal – rabbit<br /> | ||
| - | **[[4hls]], [[4hmm]], [[4hmr]]- rPrP C-terminal (mutant)<br /> | ||
| - | **[[2fj3]] - rPrP C-terminal – NMR<br /> | ||
| - | **[[2joh]], [[2jom]] - rPrP C-terminal (mutant) – NMR<br /> | ||
| - | **[[1xyw]] – ePrP C terminal - NMR<br /> | ||
| - | **[[2ku4]] - PrP C-terminal – horse<br /> | ||
| - | **[[3fva]] - ePrP C-terminal – NMR<br /> | ||
| - | **[[2kfl]] - PrP C-terminal – Wallaby – NMR<br /> | ||
| - | **[[2k56]] - PrP C-terminal – Vole – NMR<br /> | ||
| - | **[[2ktm]] – sPrP residues 167-234 H2H3 domain (mutant) – NMR<br /> | ||
| - | **[[1xyu]], [[1y2s]] - sPrP C-terminal – NMR<br /> | ||
| - | **[[1uw3]] - sPrP C-terminal<br /> | ||
| - | **[[3haf]], [[3hak]], [[3hj5]], [[1i4m]] - hPrP C-terminal<br /> | ||
| - | **[[1hjm]], [[1hjn]], [[2kun]] – hPrP C-terminal – NMR<br /> | ||
| - | **[[1h0l]], [[1fkc]], [[2k1d]], [[1fo7]], [[1e1s]], [[1e1g]], [[1e1j]], [[1e1p]], [[1e1u]], [[1e1w]], [[1qlx]], [[1qlz]], [[1qm0]], [[1qm1]], [[1qm2]], [[1qm3]], [[1qlz]], [[1qm0]], [[1qm1]], [[2lej]]- hPrP C-terminal (mutant) - NMR<br /> | ||
| - | **[[3heq]], [[3her]], [[3hes]], [[3hjx]] - hPrP C-terminal (mutant)<br /> | ||
| - | **[[2lft]], [[2lsb]], [[2m8t]] - hPrP residues 90 -231 – NMR<br /> | ||
| - | **[[2lv1]] - hPrP residues 90 -231 (mutant) – NMR<br /> | ||
| - | **[[2lsb]] - hPrP residues 120 -230 + antibody<br /> | ||
| - | **[[2ku5]], [[2ku6]], [[2kfm]], [[2kfo]], [[2k5o]], [[1y16]], [[1y15]] - mPrP C-terminal (mutant) - NMR<br /> | ||
| - | **[[1xyx]] - mPrP C-terminal - NMR<br /> | ||
| - | **[[2l1k]], [[2l1d]], [[2l1e]], [[2l40]] - mPrP C terminal (mutant) – NMR<br /> | ||
| - | **[[1ag2]], [[2l1h]], [[2l39]] - mPrP C terminal - NMR<br /> | ||
| - | **[[1u3m]] – PrP C-terminal – chicken – NMR<br /> | ||
| - | **[[1u5l]] - PrP C-terminal – turtle – NMR<br /> | ||
| - | **[[1xu0]] - PrP C-terminal – frog – NMR<br /> | ||
| - | **[[1xyj]] - PrP C-terminal – cat – NMR<br /> | ||
| - | **[[1xyk]] - PrP C-terminal – dog – NMR<br /> | ||
| - | **[[1xyq]] - PrP C-terminal – pig – NMR<br /> | ||
| - | **[[1dwy]], [[1dx0]], [[1dx1]] - bPrP C-terminal – NMR<br /> | ||
| - | **[[1dwz]] - bPrP C-terminal (mutant) - NMR<br /> | ||
| - | **[[1b10]] - ShPrP C-terminal – NMR<br /> | ||
| - | **[[2lh8]] - ShPrP C-terminal + thiamine – NMR | ||
| - | |||
| - | *Yeast prions | ||
| - | |||
| - | **[[2onx]], [[2olx]] – Sup35 residues 8 - 11 – yeast<br /> | ||
| - | **[[2omm]], [[1yjo]], [[1yjp]] – Sup35 residues 7 – 13<br /> | ||
| - | **[[1jzr]], [[1k0a]], [[1k0b]], [[1k0c]], [[1k0d]] – Ure2p + glutathione derivartive<br /> | ||
| - | **[[1g6w]], [[1g6y]] – Ure2p globular domain<br /> | ||
| - | **[[1hqo]] – Ure2p nitrogen regulation fragment | ||
| - | |||
| - | *Prion complex with antibody | ||
| - | |||
| - | **[[2w9e]], [[4h88]] - hPrP C-terminal + anti-PrP antibody<br /> | ||
| - | **[[2lsb]], [[4dgi]] - hPrP residues 120 -230 + antibody<br /> | ||
| - | **[[4j8r]] - mPrP residues 67-82 + antibody<br /> | ||
| - | **[[4ma7]], [[4ma8]] - mPrP residues 116 - 229 + antibody<br /> | ||
| - | **[[4n9o]] - hPrP C terminal + nanobody<br /> | ||
| - | **[[4kml]] - hPrP + nanobody<br /> | ||
| - | **[[2hh0]] - bPrP peptide epitope + anti-PrP antibody<br /> | ||
| - | **[[1cu4]] - ShPrP peptide epitope + anti-PrP antibody<br /> | ||
| - | **[[1tpx]], [[1tqb]], [[1tqc]] - sPrP C-terminal + anti-PrP antibody | ||
| - | |||
| - | *HET-S from ''Podospora anserine'' | ||
| - | |||
| - | **[[2kj3]], [[2rnm]] – HET-S C-terminal – NMR<br /> | ||
| - | **[[2wvn]], [[2wvo]] - HET-S N-terminal<br /> | ||
| - | **[[2wvq]] - HET-S N-terminal (mutant) | ||
| - | }} | ||
<references/> | <references/> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
- ↑ Cong X, Bongarzone S, Giachin G, Rossetti G, Carloni P, Legname G. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras. J Biomol Struct Dyn. 2012 Aug 30. PMID:22934595 doi:10.1080/07391102.2012.712477

